Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.4.1.41 extracted from

  • Hintze, J.; Ye, Z.; Narimatsu, Y.; Madsen, T.D.; Joshi, H.J.; Goth, C.K.; Linstedt, A.; Bachert, C.; Mandel, U.; Bennett, E.P.; Vakhrushev, S.Y.; Schjoldager, K.T.
    Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines (2018), J. Biol. Chem., 293, 19064-19077 .
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
analysis development of isogenic cell-model systems withTet-On inducible expression of GalNAc-T genes GALNT2 and GALNT11 in a knockout background in HEK-293 cells to identify O-glycopeptides differentially affected by induction of GalNAc-T2 or -T11 Homo sapiens

Cloned(Commentary)

Cloned (Comment) Organism
expression in HEK-293 cell Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens Q10471 isoform GalNAc-T2
-
Homo sapiens Q8NCW6 isoform GalNAc-T11
-

Synonyms

Synonyms Comment Organism
GalNAc-T11
-
Homo sapiens
GalNAc-T2
-
Homo sapiens
GALNT11
-
Homo sapiens
GALNT2
-
Homo sapiens

General Information

General Information Comment Organism
physiological function isoform GalNAc-T11-specific glycosites are glycosylated in a dose-dependent manner and induction of GalNAc-T11 produces discrete glycosylation effects without affecting the major part of the O-glycoproteome. Responder proteins are the LA-2 module in VLDLR (70KTCAESDFVCNNGQCVPSR88), a glycosite just C-terminal to the single LA module in SPINT1 (328HPVCSGTCQPTQFR341), a class A repeat in LRP1 (873CDGDNDCLDNSDEAPALCHQHTCPSDR899), BCR-associated protein 29/BCAP29, cathepsin D/CTSD, neuferricin/CYB5D2, HLA-A, GRP-78/HSPA5/BiP, podocalyxin/PODXL, xyloside xylosyltransferase 1/XXYLT1, and golgin 1/GLG1 Homo sapiens
physiological function isoform GalNAc-T2-specific glycosites are glycosylated in a dose-dependent manner and induction of GalNAc-T2 produces discrete glycosylation effects without affecting the major part of the O-glycoproteome. Responder proteins are GRP-78/HSPA5/BiP (634LYGSAGPPPTGEEDTAEKDEL654), PAPS transporter 1/SLC35B2 (137SYGATATSPGER148), 4Gal-T3/B4GALT3 (219SFPDQFSTGEPPALDEVPEVR239) (ambiguous glycosites italicized), calnexin/CANX (62APVPTGEVYFADSFDR77), GP73/GOLM1 (233SQTPAPSSEVVLDSK247 and 233SQTPAPSSE241), LRP11 (299AAYSTGGCLHTCSR312), TGN46/TGOLN2 (346MSGSASSENR355), and carboxypeptidase D/CPD (219SFPDQFSTGEPPALDEVPEVR239) Homo sapiens